Back to Business

Biohaven pauses new enrollment in epilepsy trials after FDA partial clinical hold

Business September 10, 2026 at 10:22 AM

Biohaven pauses new enrollment in epilepsy trials after FDA partial clinical hold

Investing.com

Read at Investing.com

More Stories

Deutsche Bank starts bullish Kongsberg coverage on missile growth

Deutsche Bank starts bullish Kongsberg coverage on missile growth

🇺🇸 Investing.com 29m ago

Instacart (CART) stock analysis: fundamentals solid, technicals mixed

Instacart (CART) stock analysis: fundamentals solid, technicals mixed

🇺🇸 Investing.com 30m ago

Uber stock analysis: strong fundamentals but technical signals point to caution

Uber stock analysis: strong fundamentals but technical signals point to caution

🇺🇸 Investing.com 32m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play